JavaScript Required

The P4H website is designed to perform best with Javascript enabled. Please enable it in your browser. If you need help with this, check out https://www.enable-javascript.com/

Thailand announces new benefits package for VITT diagnosis and treatment under Universal Coverage Scheme - P4H Network

Thailand announces new benefits package for VITT diagnosis and treatment under Universal Coverage Scheme

The National Health Security Board has approved laboratory testing and medication for treating vaccine-induced immune thrombotic thrombocytopenia (VITT) under the Universal Coverage Scheme (UCS)’s benefits package.

The introduction of VITT laboratory testing and treatment in the UCS’ benefits package aimed to instil confidence in the Covid-19 mass vaccination programme.

“The Thai government will take care of people experiencing adverse effects after receiving a Covid-19 vaccine,” Anutin Charnvirakul, Public Health Minister and NHS board chairman.

Vaccine recipients who experience symptoms caused by VITT can request free laboratory testing at their registered hospitals. They will receive free treatment, too, if they are diagnosed with VITT.

To know more read the entire article published in The Nation Thailand here.

Image Credits: Money Life

Have anything to say about the Thai government’s compensation policy for side effects of Covid 19 vaccines? Please let us know in the Comments Section below.

Reference
14 Jun 2021